UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(MARK ONE)

☒     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2026 

OR

☐     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to ______

Commission File No. 000-55383

32932 Pacific Coast Highway, #14-254

Dana Point, California 92629

(Address of principal executive offices, zip code)

(321) 299-2014

(Registrant’s telephone number, including area code)

_____________________________________________________

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒     No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒     No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (check one):

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Indicate by check mark whether the registrant is a shell company (as defined in Exchange Act Rule 12b-2 of the Exchange Act): Yes ☐     No ☒

As of November 6, 2026, there were 40,066,951 shares of common stock, $0.001 par value per share, outstanding.

AGENTIX CORP.

QUARTERLY REPORT ON FORM 10-Q

FOR THE PERIOD ENDED SEPTEMBER 30, 2026

INDEX

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q of Agentix Corp., a Nevada corporation (the “Company”), contains “forward-looking statements,” as defined in the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “could”, “expects”, “plans”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”, “potential” or “continue” or the negative of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market opportunity, our strategies, competition, expected activities and expenditures as we pursue our business plan, and the adequacy of our available cash resources. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Actual results may differ materially from the predictions discussed in these forward-looking statements. The economic environment within which we operate could materially affect our actual results. Additional factors that could materially affect these forward-looking statements and/or predictions include, among other things: the Company’s need for and ability to obtain additional financing, product demand, market and customer acceptance, competition, public health crises, pricing and development difficulties, as well as general industry and market conditions and growth rates, general economic conditions, and other factors over which we have little or no control; and other factors discussed in the Company’s filings with the Securities and Exchange Commission (“SEC”).

Our management has included projections and estimates in this Form 10-Q, which are based primarily on management’s experience in the industry, assessments of our results of operations, discussions and negotiations with third parties and a review of information filed by our competitors with the SEC or otherwise publicly available. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

Agentix Corp. and Subsidiaries

Consolidated Balance Sheets

See accompanying notes to the unaudited consolidated financial statements.

Agentix Corp. and Subsidiaries

Unaudited Consolidated Statements of Operations

(Amounts in U.S. dollars, except share and per share data)

See accompanying notes to the unaudited consolidated financial statements.

Agentix Corp. and Subsidiaries

Unaudited Consolidated Statements of Changes in Stockholders’ Deficit

For the Three and Six Months Ended September 30, 2026 and 2025

(Amounts in U.S. dollars, except share data)

See accompanying notes to the unaudited consolidated financial statements.

Agentix Corp. and Subsidiaries

Unaudited Consolidated Statements of Cash Flows

See accompanying notes to the unaudited consolidated financial statements.

Agentix Corp.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(unaudited)

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The following information should be read in conjunction with (i) the unaudited consolidated financial statements of Agentix Corp., a Nevada corporation (the “Company”), and the notes thereto appearing elsewhere in this Form 10-Q and (ii) the more detailed business information and audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2026. Statements in this section and elsewhere in this Form 10-Q that are not statements of historical or current fact constitute forward-looking statements.

Company Overview

We were incorporated in the State of Nevada on April 18, 2013 and we initially established a fiscal year end of August 31. In March 2022, we changed our year end to March 31.

CRITICAL ACCOUNTING POLICIES

The discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”). The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. For the periods presented, we concluded that no accounting policies required such extensive judgment or complexity that they should be classified as critical to understanding our financial condition or operating results.

Basis of Accounting

Our unaudited consolidated financial statements and related notes have been prepared in accordance with U.S. GAAP and with the rules and regulations of the SEC applicable to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim financial statements reflect all adjustments (consisting of normal recurring accruals) that, in the opinion of management, are necessary for a fair statement of the results for the interim periods presented. Unaudited interim results are not necessarily indicative of results for the full fiscal year. These financial statements should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2026.

Recent Accounting Pronouncements

Our unaudited consolidated financial statements and related notes have been prepared in accordance with U.S. GAAP and with the rules and regulations of the SEC applicable to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim financial statements reflect all adjustments (consisting of normal recurring accruals) that, in the opinion of management, are necessary for a fair statement of the results for the interim periods presented. Unaudited interim results are not necessarily indicative of results for the full fiscal year. These financial statements should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2026.

RESULTS OF OPERATIONS

Three Months Ended September 30, 2026 as compared to Three Months Ended September 30, 2025:

The Company had no revenue for the three months ended September 30, 2026 or 2025.

For the three months ended September 30, 2026, professional fees were $47,193 compared with $81,233 for the three months ended September 30, 2025, a decrease of $34,040. Current-period fees consisted of $37,500 of consulting fees, $5,993 of audit and review fees, $2,450 of accounting fees, and $1,250 of stock transfer agent fees.

For the three months ended September 30, 2026, research and development expenses were $4,191 compared with $25,079 for the three months ended September 30, 2025, a decrease of $20,888. Current-period costs were for research and development supplies and materials.

For the three months ended September 30, 2026 and 2025, general and administrative expenses were $16,785 in each period. Current-period expenses consisted of $15,000 of rent, $1,500 of computer and internet costs, and $285 of bank service charges.

For the three months ended September 30, 2026, foreign exchange gain was $302 compared with $3,149 for the three months ended September 30, 2025, a decrease of $2,847.

For the three months ended September 30, 2026, interest expense, net was $23,158 compared with $24,159 for the three months ended September 30, 2025, a decrease of $1,001. Current-period interest relates to the Gray’s Peak note.

The Company had no other income for the three months ended September 30, 2026 or 2025.

Net loss for the three months ended September 30, 2026 was $91,025 compared with $144,107 for the three months ended September 30, 2025, a decrease of $53,082, principally reflecting lower professional fees and research and development expenses. Foreign currency translation losses were $2,207 and $2,165, respectively, and total comprehensive loss was $93,232 and $146,272, respectively.

Six Months Ended September 30, 2026 as compared to Six Months Ended September 30, 2025:

The Company had no revenue for the six months ended September 30, 2026 or 2025.

For the six months ended September 30, 2026, professional fees were $109,277 compared with $163,858 for the six months ended September 30, 2025, a decrease of $54,581. Current-period fees consisted of $75,000 of consulting fees, $23,761 of audit and review fees, $5,825 of accounting fees, and $4,691 of stock transfer agent fees.

For the six months ended September 30, 2026, research and development expenses were $20,826 compared with $125,079 for the six months ended September 30, 2025, a decrease of $104,253. Current-period expenses consisted of $16,635 of patent maintenance and $4,191 of research and development supplies and materials.

For the six months ended September 30, 2026, general and administrative expenses were $33,570 compared with $34,502 for the six months ended September 30, 2025, a decrease of $932. Current-period expenses consisted of $30,000 of rent, $3,000 of computer and internet costs, and $570 of bank service charges.

For the six months ended September 30, 2026, foreign exchange gain was $302 compared with $18,289 for the six months ended September 30, 2025, a decrease of $17,987.

For the six months ended September 30, 2026, interest expense, net was $45,328 compared with $45,385 for the six months ended September 30, 2025, a decrease of $57. Current-period interest relates to the Gray’s Peak note.

For the six months ended September 30, 2026, other income was $0 compared with $20,604 for the six months ended September 30, 2025, a decrease of $20,604. The prior-period amount related to a gain on settlement of payables.

Net loss for the six months ended September 30, 2026 was $208,699 compared with $329,931 for the six months ended September 30, 2025, a decrease of $121,232. Lower professional fees and research and development expenses were partly offset by lower foreign exchange gains and other income. Foreign currency translation was a loss of $2,815 in 2026 and a gain of $16,142 in 2025. Total comprehensive loss was $211,514 and $313,789, respectively.

Liquidity and Capital Resources

Our unaudited consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates continuity of operations, realization of assets and liquidation of liabilities in the normal course of business. As of September 30, 2026, we had an accumulated deficit of $7,215,863, negative working capital of $3,807,025, cash of $1,312, and total current liabilities of $3,808,337. For the six months ended September 30, 2026, we had a net loss of $208,699 and net cash used in operating activities of $29,894.

For the six months ended September 30, 2026 and 2025, net cash used in operating activities was $29,894 and $115,367, respectively. The Company had no cash flows from investing activities in either period. Net cash provided by financing activities was $33,250 and $100,350, respectively, consisting of proceeds from note borrowings. Operating cash use decreased by $85,473, and financing cash inflows decreased by $67,100.

We are attempting to commence operations and generate sufficient revenue; however, our cash position is not sufficient to support our daily operations. As such, we will need to raise funds to complete our plan of operation and fund our ongoing operational expenses for the next 12 months. Additional funding will likely come from equity financing from the sale of our common stock or debt financing. If we are successful in completing an equity financing, existing shareholders will experience dilution of their interest in our Company and if we obtain debt financing, the terms of any such debt financing may not be favorable to existing shareholders. We cannot provide investors with any assurance that we will be able to raise sufficient funding from the sale of our common stock or obtaining debt to fund our development activities and ongoing operational expenses. In the absence of such financing, our business will likely fail. There are no assurances that we will be able to achieve further sales of our common stock or any other form of additional financing. If we are unable to achieve the financing necessary to continue our plan of operations, then we will not be able to continue our development to complete our plan of operation and our business will fail.

Off-Balance Sheet Arrangements

The Company has no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.

Subsequent Events

In accordance with ASC 855, the Company has analyzed its operations subsequent to September 30, 2026 through the date these financial statements were issued and has determined that it does not have any other material subsequent events to disclose in these financial statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

As a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act), we are not required to provide the information called for by this Item 3.

ITEM 4. CONTROLS AND PROCEDURES.

DISCLOSURE CONTROLS AND PROCEDURES

Under the supervision and with the participation of our management, including Riazul (Rehan) Huda, our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of September 30, 2026. Disclosure controls and procedures are designed to ensure that material information required to be included in our SEC reports is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and is communicated to management, including our principal executive and financial officer, as appropriate to allow timely decisions regarding required disclosure. Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of September 30, 2026.

There were no changes in the Company’s internal controls over financial reporting during the most recently completed fiscal quarter that have materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

The Company is not currently subject to any legal proceedings. From time to time, the Company may become subject to litigation or proceedings in connection with its business, as either a plaintiff or defendant. There are no such pending legal proceedings to which the Company is a party that, in the opinion of management, is likely to have a material adverse effect on the Company’s business, financial condition or results of operations.

ITEM 1A. RISK FACTORS

As a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act), we are not required to provide the information called for by this Item 1A.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

None.

ITEM 5. OTHER INFORMATION.

None.

ITEM 6. EXHIBITS.

(a) Exhibits required by Item 601 of Regulation S-K.:

_____________

*Furnished, not filed.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ATTACHMENTS / EXHIBITS

CERTIFICATION

CERTIFICATION

CERTIFICATION

XBRL TAXONOMY EXTENSION SCHEMA

XBRL TAXONOMY EXTENSION LABEL LINKBASE

XBRL TAXONOMY EXTENSION CALCULATION LINKBASE

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

XBRL TAXONOMY EXTENSION DEFINITION LINKBASE

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: R6.htm

IDEA: R7.htm

IDEA: R8.htm

IDEA: R9.htm

IDEA: R10.htm

IDEA: R11.htm

IDEA: R12.htm

IDEA: R13.htm

IDEA: R14.htm

IDEA: R15.htm

IDEA: R16.htm

IDEA: R17.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: agtx_10q_htm.xml